Active Ingredient(s): Rapacuronium
FDA Approved: * August 18, 1999
Pharm Company: * ORGANON USA INC
Category: Muscle Relaxer

Rapacuronium bromide (brand name Raplon) is a rapidly acting, non-depolarizing aminosteroid neuromuscular blocker formerly used in modern anaesthesia, to aid and enable endotracheal intubation, which is often necessary to assist in the controlled ventilation of unconscious patients during surgery and sometimes in intensive care. As a non-depolarizing agent it did not cause initial stimulation of muscles before weakening them. Due to risk of fatal bronchospasm it was withdrawn from the United ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.